bpc-157 clinical trials humans safety If worked as well as the internet says it does… …we'd probably have high quality human by now. Instead we have... Lots of rat studies. Lots of podcasts. Lots of Peptides: What they are, potential

A retrospective knee-pain chart review reported that 14 of 16 contacted patients had pain relief after intra-articular BPC-157 alone or BPC-157 with thymosin beta-4, but the study was not randomized, blinded, or controlled (PubMed)

It shows that there is a strong positive correlation between the severity of multifidus atrophy and the severity of spinal stenosis. (Xia et al.) Traction Applying traction to the lumbar spine is a great way to alleviate pain and decompress the spine

The US Anti-Doping Agency (ADA) states that because it has not been extensively studied in humans, "no-one knows if there is a safe dose, or if there is any way to use this compound safely to treat specific medical conditions"

Evidence Boundary Not supported by published human clinical trial data for dosing, absorption, or efficacy

Not sterile water, not saline, not tap water

Cycling Considerations While BPC-157 does not appear to cause receptor desensitization in the same way some compounds do, periodic breaks remain standard practice